Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Science

• Publication date

  1993-06-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1126/SCIENCE.8316834PMID 8316834
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Post-translational modification of proteins by 15-carbon and 20-carbon isoprenoids in three mammalian cell lines

  2004cited by this paper
• Pepticinnamins, new farnesyl-protein transferase inhibitors produced by an actinomycete. II. Structural elucidation of pepticinnamin E.

  1993cited by this paper
• Identification of Ras farnesyltransferase inhibitors by microbial screening.

  1993cited by this paper
• Purification of a mammalian protein geranylgeranyltransferase. Formation and catalytic properties of an enzyme-geranylgeranyl pyrophosphate complex.

  1993cited by this paper
• Pepticinnamins, new farnesyl-protein transferase inhibitors produced by an actinomycete. I. Producing strain, fermentation, isolation and biological activity.

  1993cited by this paper
• Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase.

  1993cited by this paper
• Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo.

  1993cited by this paper
• Divalent cation and prenyl pyrophosphate specificities of the protein farnesyltransferase from rat brain, a zinc metalloenzyme.

  1992cited by this paper
• Steady-state kinetic mechanism of Ras farnesyl:protein transferase.

  1992cited by this paper
• Farnesylcysteine, a constituent of the alpha and beta subunits of rabbit skeletal muscle phosphorylase kinase: localization by conversion to S-ethylcysteine and by tandem mass spectrometry.

  1992cited by this paper
• Isoprenylation in regulation of signal transduction by G-protein-coupled receptor kinases

  1992cited by this paper
• Rab geranylgeranyl transferase. A multisubunit enzyme that prenylates GTP-binding proteins terminating in Cys-X-Cys or Cys-Cys.

  1992cited by this paper
• cDNA cloning of MEV, a mutant protein that facilitates cellular uptake of mevalonate, and identification of the point mutation responsible for its gain of function.

  1992cited by this paper
• Inhibition of farnesyl-protein transferase by gliotoxin and acetylgliotoxin.

  1992cited by this paper
• Small GTP-binding proteins.

  1992cited by this paper
• Protein prenylation: genes, enzymes, targets, and functions.

  1992cited by this paper
• Tetrapeptide inhibitors of protein farnesyltransferase: amino-terminal substitution in phenylalanine-containing tetrapeptides restores farnesylation.

  1992cited by this paper
• Purification of component A of Rab geranylgeranyl transferase: possible identity with the choroideremia gene product.

  1992cited by this paper
• Cloning and expression of a cDNA encoding the alpha subunit of rat p21ras protein farnesyltransferase.

  1991cited by this paper
• Nonfarnesylated tetrapeptide inhibitors of protein farnesyltransferase.

  1991cited by this paper
• Sequence requirement for peptide recognition by rat brain p21ras protein farnesyltransferase.

  1991cited by this paper
• Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras

  1991cited by this paper
• Regulators and effectors of ras proteins.

  1991cited by this paper
• Enzymatic modification of proteins with a geranylgeranyl isoprenoid.

  1991cited by this paper
• Protein farnesyltransferase and geranylgeranyltransferase share a common alpha subunit.

  1991cited by this paper
• cDNA cloning and expression of the peptide-binding beta subunit of rat p21ras farnesyltransferase, the counterpart of yeast DPR1/RAM1.

  1991cited by this paper
• Sequence dependence of protein isoprenylation.

  1991cited by this paper
• Ras C-terminal processing enzymes--new drug targets?

  1991cited by this paper
• Protein farnesyltransferase and geranylgeranyltransferase share a common α subunit

  1991cited by this paper
• Posttranslational modification of proteins by isoprenoids in mammalian cells

  1990cited by this paper
• Inhibition of purified p21ras farnesyl:protein transferase by Cys-AAX tetrapeptides.

  1990cited by this paper
• Conformational constraints: Nonpeptide β‐turn mimics

  1990cited by this paper
• Prenylated proteins: the structure of the isoprenoid group.

  1990cited by this paper
• Structural consequences of effector binding to the T state of aspartate carbamoyltransferase: crystal structures of the unligated and ATP- and CTP-complexed enzymes at 2.6-A resolution.

  1990cited by this paper
• Linearization of baculovirus DNA enhances the recovery of recombinant virus expression vectors.

  1990cited by this paper
• Identification of geranylgeranyl-modified proteins in HeLa cells.

  1990cited by this paper
• Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans.

  1989cited by this paper
• Human lamin B contains a farnesylated cysteine residue.

  1989cited by this paper
• p21ras is modified by a farnesyl isoprenoid.

  1989cited by this paper
• Non-peptide ligands for peptide receptors.

  1989cited by this paper
• All ras proteins are polyisoprenylated but only some are palmitoylated.

  1989cited by this paper
• Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP

  1988cited by this paper
• Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.

  1988cited by this paper
• Expression of specific high capacity mevalonate transport in a Chinese hamster cell variant.

  1987cited by this paper
• ras genes.

  1987cited by this paper
• Synthesis and resolution of 3-amino-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-ones

  1987cited by this paper
• Requirement for c-ras proteins during viral oncogene transformation

  1986cited by this paper
• Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein

  1985cited by this paper
• Biological properties of human c-Ha-ras1 genes mutated at codon 12

  1984cited by this paper
• The Cambridge Crystallographic Data Centre: computer-based search, retrieval, analysis and display of information

  1979cited by this paper
• Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase.

  1978cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?

  2024cites this paper
• A Synthetic Overview of Benzoxazines and Benzoxazepines as Anticancer Agents

  2023cites this paper
• Mild and Highly Efficient Method for Synthesis of 1,5-Benzodiazepine Using Pentafluorobenzenaminium hexafluorophosphate as a Novel Organocatalyst

  2022cites this paper
• Synthesis and inhibition studies towards the discovery of benzodiazepines as potential antimalarial compounds.

  2022cites this paper
• Tyrosine-Derived Novel Benzoxazine Active in a Rat Syngenic Mammary Tumor Model of Breast Cancer.

  2021cites this paper
• Ras Signaling in Breast Cancer.

  2021cites this paper
• Potential of Farnesyl Transferase Inhibitors in Combination Regimens in Squamous Cell Carcinomas

  2021cites this paper
• Insights into the post-translational modification and its emerging role in shaping the tumor microenvironment

  2021cites this paper
• Mechanisms of CaaX Protein Processing: Protein Prenylation by FTase and GGTase-I

  2020cites this paper
• Small molecule inhibitors of RAS proteins with oncogenic mutations

  2020cites this paper
• Biology, pathology, and therapeutic targeting of RAS.

  2020cites this paper
• Bioblockades join the assault on small G protein signalling.

  2019cites this paper
• Asymmetric Ir-catalyzed hydrogenation of 1,3-dihydro-2H-1,5-benzodiazepin-2-ones using phosphoramidites

  2018cites this paper
• K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives.

  2017cites this paper
• Cysteine-based 3-substituted 1, 5-benzoxathiepin derivatives: Two new classes of anti-proliferative agents

  2017cites this paper
• Farnesyltransferase-Mediated Delivery of a Covalent Inhibitor Overcomes Alternative Prenylation to Mislocalize K-Ras.

  2017cites this paper
• Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design

  2016cites this paper
• Past, Present, and Future of Targeting Ras for Cancer Therapies.

  2016cites this paper
• Evaluating the therapeutic potential of the PAK1 and TBK1 kinases in pancreatic ductal adenocarcinoma

  2016cites this paper
• Microwave-Assisted Syntheses of Bioactive Seven-Membered, Macro-Sized Heterocycles and Their Fused Derivatives

  2016cites this paper
• The Design Development of Small Molecule Inhibitors Targeting Unregulated Transcription Factors in Acute Myeloid Leukemia

  2015cites this paper
• Pharmacological Inhibition of Protein Lipidation

  2015cites this paper
• Phase I study of S-trans, trans-farnesylthiosalicylic acid (salirasib), a novel oral RAS inhibitor in patients with refractory hematologic malignancies.

  2015cites this paper
• Pancreatic cancer: current management and treatment strategies

  2015cites this paper
• Progerin Expression Disrupts Critical Adult Stem Cell Functions that Mediate Tissue Repair Primarily through a Mechanism that Permanently Farnesylates Lamin A

  2015cites this paper
• Amino acid chirons: a tool for asymmetric synthesis of heterocycles.

  2014cites this paper
• Genetic determinants and potential therapeutic targets for pancreatic adenocarcinoma

  2014cites this paper
• Rational design of small molecule inhibitors targeting the Ras GEF, SOS1.

  2014cites this paper
• CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies

  2014cites this paper
• Molecular Insights into the Interaction between Plasmodium falciparum Apical Membrane Antigen 1 and an Invasion-Inhibitory Peptide

  2014cites this paper
• Recent development in [1,4]benzodiazepines as potent anticancer agents: a review.

  2014cites this paper
• General aspects of protein prenylation The importance of FT and GGT 1 for normal physiology and tumorigenesis : lessons from knockout mice

  2014cites this paper
• Amino acids derived benzoxazepines: design, synthesis and antitumor activity.

  2013cites this paper
• in therapy Farnesyltransferase inhibitors in hematologic malignancies: new horizons

  2013cites this paper
• AN INSIGHT INTO MEDICINAL AND BIOLOGICAL SIGNIFICANCE OF PRIVILEGED SCAFFOLD: 1,4-BENZODIAZEPINE

  2013cites this paper
• Targeting Protein Prenylation in Progeria

  2013cites this paper
• Chemical biology of lipidated proteins.

  2012cites this paper
• Melanoma: from mutations to medicine.

  2012cites this paper
• Severe hepatocellular disease in mice lacking one or both CaaX prenyltransferases[S]

  2012cites this paper
• 5 – Neurogenetics and the molecular biology of human brain tumors

  2012cites this paper
• Targeting the RAS pathway in melanoma.

  2012cites this paper
• Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules.

  2012cites this paper
• Predictive in vivo animal models and translation to clinical trials.

  2012cites this paper
• Scientific Side Trips: Six Excursions from the Beaten Path

  2012cites this paper
• Chapter 2 – Physiological Structure and Function of Proteins

  2012cites this paper
• Inhibitors of protein geranylgeranyltransferase-I lead to prelamin A accumulation in cells by inhibiting ZMPSTE24

  2012cites this paper
• Differential Activity of the KRAS Oncogene by Method of Activation: Implications for Signaling and Therapeutic Intervention

  2012cites this paper
• treatment for hematologic malignancies? Targeting the Ras signaling pathway: a rational, mechanism-based

  2011cites this paper
• Targeting protein prenylation for cancer therapy

  2011cites this paper
• Chapter 6 – Geranylgeranyltransferase-1 Inhibitors

  2011cites this paper
• Signaling Cross-Talk of Oncogenic KRAS and Hedgehog Pathways in Pancreatic Cancer

  2011cites this paper
• One-pot microwave-assisted synthesis and antimalarial activity of ferrocenyl benzodiazepines

  2011cites this paper
• Therapeutic strategies for targeting ras proteins.

  2011cites this paper
• Inhibition of Ras for cancer treatment: the search continues.

  2011cites this paper
• Lipid Modification of Ras Superfamily GTPases: Not Just Membrane Glue

  2011cites this paper
• Synthesis of a Multifunctional Oxazolo(5,4-e)(1,4)diazepine Skeleton

  2011cites this paper
• Diversity‐Oriented Synthesis of Privileged Heterocycles Using Divergent Strategy

  2011cites this paper
• Chapter 222 – Farnesyltransferase Inhibitors

  2010cites this paper
• Genetic and functional characterization of putative Ras/Raf interaction inhibitors in C. elegans and mammalian cells

  2010cites this paper
• Treatment of Peripheral Nerve Tumors

  2010cites this paper
• Genetic studies on the functional relevance of the protein prenyltransferases in skin keratinocytes.

  2010cites this paper
• Ras history

  2010cites this paper
• Aberrant Signalling Complexes in GBMs: Prognostic and Therapeutic Implications

  2010cites this paper
• Anti-tumor activity of a new series of benzoxazepine derivatives in breast cancer.

  2010cites this paper
• Synthesis Of Some Novel C3 Substituted New Diazo-(1,4)-Benzodiazepine-2- One Derivatives As Potent Anticonvulsants

  2010cites this paper
• Farnesyltransferase inhibitors: where are we now?

  2010cites this paper
• Salirasib in the treatment of pancreatic cancer.

  2010cites this paper
• First Highly Enantioselective Synthesis of Benzodiazepinones by Catalytic Hydrogenation

  2010cites this paper
• A Novel Conversion of 2, 4‐Diaryl‐2, 3‐dihydro‐1 H‐1, 5‐benzodiazepines into 2, 4‐Diaryl‐3 H‐1, 5‐benzodiazepines

  2010cites this paper
• Amino acid based enantiomerically pure 3-substituted benzofused heterocycles: A new class of antithrombotic agents.

  2010cites this paper
• Small G protein signaling in neuronal plasticity and memory formation: the specific role of ras family proteins.

  2010cites this paper
• Design of Peptidomimetics

  2010cites this paper
• Palmitoyl acyltransferase assays and inhibitors (Review)

  2009cites this paper
• Clinical evaluation of biologically targeted drugs: Obstacles and opportunities

  2009cites this paper
• A Systems Perspective of Ras Signaling in Cancer

  2009cites this paper
• Phase 1 first-in-human clinical study of S-trans, trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors

  2009cites this paper
• RhoA, B, and C in cancer: Study of statin-induced changes in Rho signaling, and identification of isoform-specific Rho effectors

  2009cites this paper
• Mass spectrometric studies of potent inhibitors of farnesyl protein transferase--detection of pentameric noncovalent complexes.

  2008cites this paper
• Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models.

  2008cites this paper
• Identification of Human DHHC20 as a Transforming Palmitoyl Acyltransferase

  2008influential citation
• Identification of RabGGTase inhibitors and mechanistic studies of Rab GTPase prenylation and recyling using fluorescent sensors

  2008cites this paper
• Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem.

  2008cites this paper
• An efficient approach to chiral C8/C9-piperazino-substituted 1,4-benzodiazepin-2-ones as peptidomimetic scaffolds.

  2008cites this paper
• Inhibitors of chronically active ras: potential for treatment of human malignancies.

  2008cites this paper
• Conception, synthèse et évaluation pharmacologique d'inhibiteurs potentiels de farnésyltransférase dans le traitement du cancer

  2008cites this paper
• Facile and Efficient One‐Pot Protocol for Synthesis of 5‐Phenyl‐1,4‐benzodiazepine‐2‐one Derivatives

  2008cites this paper
• Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation.

  2008cites this paper
• Inhibition of farnesyltransferase: A rational approach to treat cancer?

  2007cites this paper
• Amino acid-based enantiomerically pure 3-substituted 1,4-benzodiazepin-2-ones: a new class of anti-ischemic agents.

  2007cites this paper
• 2.15 – Peptidomimetic and Nonpeptide Drug Discovery: Receptor, Protease, and Signal Transduction Therapeutic Targets

  2007cites this paper
• Diversity-oriented synthetic approach to naturally abundant S-amino acid based benzannulated enantiomerically pure medium ring heterocyclic scaffolds employing inter- and intramolecular mitsunobu reactions.

  2007cites this paper
• Farnesyl Transferase Inhibitors in Cancer: Promise, but Limited Proof

  2007cites this paper
• Synthesis of a fluorescent analogue of geranylgeranyl pyrophosphate and its use in a high-throughput fluorometric assay for Rab geranylgeranyltransferase

  2007cites this paper
• Cellular palmitoylation and trafficking of lipidated peptides Published, JLR Papers in Press, May 24, 2007.

  2007cites this paper
• Approaching the Treatment of AML from a Biological Perspective

  2007cites this paper
• Novel application of Leuckart-Wallach reaction for synthesis of tetrahydro-1,4-benzodiazepin-5-ones library.

  2007cites this paper
• Farnesyltransferase pharmacophore model derived from diverse classes of inhibitors.

  2007cites this paper
• Network Analysis of Oncogenic Ras Activation in Cancer

  2007cites this paper
• Mechanistic Studies on Memory of Chirality Alkylations of 1,4-Benzodiazepin-2-ones & Structure-based Design of Insecticidal AChE Inhibitors for Malaria Mosquito, Anopheles gambiae

  2007influential citation
• Molecular, Genetic, and Cellular Pathogenesis of Neurofibromas and Surgical Implications

  2006cites this paper